Orion Oyj (ORINF)
78.95
0.00 (0.00%)
USD |
OTCM |
Feb 19, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 11.11B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 67.23% |
| Valuation | |
| PE Ratio | 19.38 |
| PE Ratio (Forward) | |
| PS Ratio | 5.164 |
| Price to Book Value | 7.363 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 1.068 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.2378 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 20.69% |
Profile
| Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. It specializes in central nervous system disorders, oncology, and respiratory diseases. The firm's customers are specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centers, clinics, and laboratories. The company was founded by Onni Turpeinen, Eemil Tuurala and Wikki Valkama on September 21, 1917 and is headquartered in Espoo, Finland. |
| URL | http://www.orionpharma.com |
| Investor Relations URL | N/A |
| HQ State/Province | Uusimaa |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Apr. 23, 2026 |
| Last Earnings Release | Feb. 12, 2026 |
| Next Ex-Dividend Date | Mar. 26, 2026 |
| Last Ex-Dividend Date | Oct. 16, 2025 |
Profile
| Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. It specializes in central nervous system disorders, oncology, and respiratory diseases. The firm's customers are specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centers, clinics, and laboratories. The company was founded by Onni Turpeinen, Eemil Tuurala and Wikki Valkama on September 21, 1917 and is headquartered in Espoo, Finland. |
| URL | http://www.orionpharma.com |
| Investor Relations URL | N/A |
| HQ State/Province | Uusimaa |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Apr. 23, 2026 |
| Last Earnings Release | Feb. 12, 2026 |
| Next Ex-Dividend Date | Mar. 26, 2026 |
| Last Ex-Dividend Date | Oct. 16, 2025 |